Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
S Villapol - Translational Research, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the
greatest worldwide pandemic since the 1918 flu. The consequences of the coronavirus …
greatest worldwide pandemic since the 1918 flu. The consequences of the coronavirus …
Sex differences in severity and mortality from COVID-19: are males more vulnerable?
A Pradhan, PE Olsson - Biology of sex Differences, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) has shown high infection and mortality rates
all over the world, and despite the global efforts, there is so far no specific therapy available …
all over the world, and despite the global efforts, there is so far no specific therapy available …
Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)
A Bhimraj, RL Morgan, AH Shumaker… - Clinical Infectious …, 2020 - academic.oup.com
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
[HTML][HTML] Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study
G Annweiler, M Corvaisier, J Gautier, V Dubée… - Nutrients, 2020 - mdpi.com
Background. The objective of this quasi-experimental study was to determine whether bolus
vitamin D supplementation taken either regularly over the preceding year or after the …
vitamin D supplementation taken either regularly over the preceding year or after the …
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19
H Kai, M Kai - Hypertension Research, 2020 - nature.com
The rapid spread of a novel coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has led to an ongoing pandemic of coronavirus disease 2019 (COVID-19) …
(SARS-CoV-2), has led to an ongoing pandemic of coronavirus disease 2019 (COVID-19) …
Vitamin D and survival in COVID-19 patients: A quasi-experimental study
C Annweiler, B Hanotte, CG de l'Eprevier… - The Journal of steroid …, 2020 - Elsevier
Vitamin D may be a central biological determinant of COVID-19 outcomes. The objective of
this quasi-experimental study was to determine whether bolus vitamin D3 supplementation …
this quasi-experimental study was to determine whether bolus vitamin D3 supplementation …
Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports
S Najjar, A Najjar, DJ Chong, BK Pramanik… - Journal of …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a highly infectious pandemic caused by a
novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …
novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …
Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19
M Vaduganathan, O Vardeny, T Michel… - … England Journal of …, 2020 - Mass Medical Soc
RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone
system blockers on angiotensin-converting enzyme 2 levels and activity in humans are …
system blockers on angiotensin-converting enzyme 2 levels and activity in humans are …
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
K Farsalinos, A Barbouni, R Niaura - Internal and emergency medicine, 2020 - Springer
The effects of smoking on Corona Virus Disease 2019 (COVID-19) are currently unknown.
The purpose of this study was to systematically examine the prevalence of current smoking …
The purpose of this study was to systematically examine the prevalence of current smoking …
[HTML][HTML] SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
PK Datta, F Liu, T Fischer, J Rappaport, X Qin - Theranostics, 2020 - ncbi.nlm.nih.gov
The COVID-19 pandemic is an emerging threat to global public health. While our current
understanding of COVID-19 pathogenesis is limited, a better understanding will help us …
understanding of COVID-19 pathogenesis is limited, a better understanding will help us …